Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Oct;76(4):E71-E72.
doi: 10.1002/hep.32522. Epub 2022 Jun 10.

Letter to the editor: A revised electronic version of RUCAM for the diagnosis of drug-induced liver injury

Harshad Devarbhavi  1 , Sunu Sara Kurien
Affiliations
Comment

Letter to the editor: A revised electronic version of RUCAM for the diagnosis of drug-induced liver injury

Harshad Devarbhavi et al. Hepatology. 2022 Oct.
No abstract available

PubMed Disclaimer

Comment in

Comment on

  • A revised electronic version of RUCAM for the diagnosis of DILI.
    Hayashi PH, Lucena MI, Fontana RJ, Bjornsson ES, Aithal GP, Barnhart H, Gonzalez-Jimenez A, Yang Q, Gu J, Andrade RJ, Hoofnagle JH. Hayashi PH, et al. Hepatology. 2022 Jul;76(1):18-31. doi: 10.1002/hep.32327. Epub 2022 Mar 22. Hepatology. 2022. PMID: 35014066 Free PMC article.

References

    1. Hayashi PH, Lucena MI, Fontana RJ, Bjornsson ES, Aithal GP, Barnhart H, et al. A revised electronic version of RUCAM for the diagnosis of DILI. Hepatology. 2022;76:18–31.
    1. Devarbhavi H, Joseph T, Kumar NS, Rathi C, Thomas V, Singh SP, et al. The Indian network of drug‐induced liver injury: etiology, clinical features, outcome and prognostic markers in 1288 patients. J Clin Exp Hepatol. 2021;11:288–98.
    1. Shen T, Liu Y, Shang J, Xie Q, Li J, Yan M, et al. Incidence and etiology of drug‐induced liver injury in mainland China. Gastroenterology. 2019;156:2230–41.
    1. Stephens C, Robles‐Diaz M, Medina‐Caliz I, Garcia‐Cortes M, Ortega‐Alonso A, Sanabria‐Cabrera J, et al. Comprehensive analysis and insights gained from long‐term experience of the Spanish DILI Registry. J Hepatol. 2021;75:86–97.
    1. Sharma SK, Singla R, Sarda P, Mohan A, Makharia G, Jayaswal A, et al. Safety of 3 different reintroduction regimens of antituberculosis drugs after development of antituberculosis treatment‐induced hepatotoxicity. Clin Infect Dis. 2010;50:833–9.

MeSH terms